FDA Approves Drug for Thrombocytopenia in Adults with Chronic Liver Disease
On May 21, 2018, the Food and Drug Administration approved avatrombopag (Doptelet, AkaRx Inc.) for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
In Person Meeting & NetworkingMay 6, 2026 at 8:00 AM EDT560 King Street, Charleston, SC, USAHyatt Place + Hyatt House Charleston - Historic District, Charleston
Precision in Practice: Translating MRD Into Oncology Care
In Person Conference & ConventionApril 28, 2026 at 5:30 PM EDT1020 South Calhoun Street, Fort Wayne, IN, USAHilton Fort Wayne at the Grand Wayne Center, Fort Wayne
In Person Conference & ConventionApril 28, 2026 at 5:15 PM CDT1111 East Broadway, Columbia, MO, USAThe Broadway Columbia (A DoubleTree by Hilton), Columbia
